The Rose Optometry Dry Eye Drop Formulary: Chemical Composition and DEWS III-Based Use
✔ Stock on hand — every product in this formulary ships NZ-wide from Rose Optometry, Hamilton.
By Jagrut Lallu — BOptom (Hons), MSc Specialty Lenses (Hons), FIAOMC. Therapeutic Optometrist & Contact Lens Specialist. Founder, New Zealand Eye Research Centre; Partner, Rose Optometry.
Tear supplements remain the cornerstone of dry eye disease (DED) management. The TFOS DEWS III Management and Therapy report (2025) positions them as first-line therapy, working to replenish, conserve and stabilise the tear film. But the modern shelf is crowded, and two drops that look identical on a pharmacy shelf can be built on entirely different chemistry and intended for entirely different disease. This formulary sets out every dry eye drop, gel and ointment stocked at Rose Optometry, Hamilton, and maps each one — by its active chemistry — to the DEWS III framework a clinician actually prescribes within.
Matching the Drop to the Disease: The DEWS III Framework
DED is not one condition. TFOS DEWS classifies it into aqueous-deficient dry eye (too little tear volume), evaporative dry eye (usually meibomian gland dysfunction, where the lipid layer fails and tears evaporate too fast), and the mixed disease most patients actually have. Underlying all subtypes is a core mechanism of tear hyperosmolarity and surface inflammation — the self-perpetuating vicious circle of DED.
Tear-supplement chemistry maps onto this. Viscosity-enhancing demulcents (hyaluronic acid, carmellose/CMC, hydroxypropyl guar, PEG, hypromellose, dextran) primarily address aqueous deficiency. Lipid-containing formulations (mineral oil, phospholipid emulsions, perfluorohexyloctane) address evaporative disease by restoring the lipid layer. Osmoprotectants (trehalose, ectoine) counter hyperosmolarity at the cellular level. DEWS III is explicit that preservative load matters: preservatives such as benzalkonium chloride are toxic to the ocular surface with chronic use.
The Rose Optometry Drop Formulary
| Product | Core Chemistry | DEWS III Target | Preservative | Clinical Role |
|---|---|---|---|---|
| Hylo-Forte | Sodium hyaluronate 0.2% | Aqueous-deficient / mixed | PF (COMOD) | Moderate–severe lubrication, long residence |
| Hylo-Fresh | Sodium hyaluronate 0.1% | Aqueous-deficient | PF (COMOD) | Mild dryness, screen fatigue |
| Hylo-Dual | Sodium hyaluronate + ectoine | Mixed + allergic/inflammatory | PF (COMOD) | Dryness with allergic or inflammatory surface |
| Avizor Lacrifresh | Sodium hyaluronate 0.15% | Aqueous-deficient | PF | Contact-lens-compatible lubrication |
| Systane Hydration UD | HA + HP-guar + PEG (unit dose) | Aqueous-deficient / mixed | PF | Dual-polymer lubrication, post-surgical |
| Systane Ultra | PEG-400 + propylene glycol + HP-guar | Aqueous-deficient | PF single dose / preserved multidose | Fast-acting environmental relief |
| Systane Complete PF | Propylene glycol + HP-guar + nano mineral-oil | Mixed (aqueous + evaporative) | PF | All-subtype all-in-one drop |
| Polytears | Dextran 70 + hypromellose 0.3% | Aqueous-deficient | Preserved | Economical everyday tear |
| TheraTears Drops | Carmellose 0.25%, hypotonic, electrolyte-balanced | Aqueous-deficient + hyperosmolar | PF / perborate | Counters tear hyperosmolarity |
| OCuSOFT Retaine CMC | Carmellose + cationic oil-in-water nano-emulsion | Mixed / MGD | PF | Restores aqueous and lipid together |
| Systane Balance | Propylene glycol + mineral oil + phospholipid (LipiTech) | Evaporative / MGD | Preserved (Polyquad) | Restores lipid layer in MGD |
| NovaTears | Perfluorohexyloctane (F6H8) 100%, water-free | Evaporative / MGD | PF | Ultrathin anti-evaporative film |
| Rohto Dry Aid | HP-guar + TPGS vitamin-E derivative | Evaporative / mixed | Preserved | Non-blurring evaporative relief |
| Systane Gel Drops | PEG-400 + HP-guar (high viscosity) | Aqueous-deficient / severe | Preserved | Long-lasting / bridging to night |
| TheraTears Gel | Carmellose 1%, hypotonic electrolyte | Aqueous-deficient / severe | PF unit dose | Moderate–severe, night-time |
| Viscotears Liquid Gel | Carbomer 980 (polyacrylic acid) 0.2% | Evaporative / aqueous | Preserved | High-retention gel for daytime |
| Viscotears Gel PF | Carbomer 980 0.2% | Evaporative / aqueous | PF unit dose | Same gel for preservative-sensitive eyes |
| Poly Visc | White soft paraffin + liquid paraffin + wool fat | Evaporative / exposure | Preserved | Night-time protective ointment |
| Vita-POS | Retinol palmitate (vitamin A) in paraffin base | Evaporative / exposure | PF | Night ointment for exposure / lagophthalmos |
| Optimel Manuka Eye Drops | Standardised manuka honey ~16% | Evaporative / MGD + blepharitis | PF | Antibacterial and osmotic lid-margin support |
| Optimel Manuka Forte Gel | Standardised manuka honey ~98% | MGD / blepharitis | PF | Higher-strength night application |
| AEON NaCl 5% | Hypertonic sodium chloride 5% | Adjunct — corneal oedema | PF | Osmotic corneal deturgescence (not a comfort drop) |
| Cromo-Fresh | Sodium cromoglycate 2% | Adjunct — allergic surface | PF | Allergic conjunctivitis overlapping DED |
Aqueous Replacement: Hyaluronic Acid
Hyaluronic acid (HA) is the most important single molecule in the modern dry eye formulary. It has strong water-binding and shear-thinning behaviour — viscous when the eye is still, thinning on the blink so it does not blur vision. DEWS III cites a systematic review of 18 studies showing HA-containing supplements outperform non-HA supplements for ocular staining and symptoms. Hylo-Forte and Hylo-Fresh are graded by HA concentration (0.2% and 0.1%), so severity of aqueous deficiency guides the choice. All are preservative-free; Hylo's COMOD multidose valve delivers over 300 preservative-free doses per bottle.
Lipid-Based and Water-Free Formulations
Where the problem is evaporation, replacing water is not enough — the lipid layer must be restored. DEWS III reports lipid-containing supplements outperform non-lipid drops in evaporative and mixed DED. Systane Balance uses a mineral-oil and phospholipid system built specifically for MGD. NovaTears (perfluorohexyloctane) is a water-free, preservative-free semifluorinated alkane that spreads as an ultrathin film to physically slow evaporation — with Phase III randomised trial evidence.
Gels and Night-Time Ointments
Heavier agents are positioned for severe disease and overnight use. Viscotears Gel PF (carbomer, preservative-free unit dose) sits between a drop and an ointment. For the night, Vita-POS (vitamin A in paraffin, preservative-free) and Poly Visc protect the surface through the hours of reduced blinking.
Preservative-Free Options at Rose Optometry
DEWS III is unambiguous: benzalkonium chloride is toxic to the ocular surface with chronic use. The formulary above is weighted heavily toward preservative-free options. Browse our full preservative-free eye drops range or the complete dry eye drops collection.
References
- Jones L, Craig JP, Markoulli M, et al. TFOS DEWS III: Management and Therapy. American Journal of Ophthalmology. 2025;279:289-386.
- Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification. The Ocular Surface. 2017;15(3):276-283.